The international business section was established in October 2018, it mainly to develop innovative drugs and provide international R&D services. There are international drug R&D and cooperation platforms (traditional drugs, nucleic acid drugs, atomized inhalation and nano-gels, etc.) and nucleic acid drug R&D platforms. They are also engaged in the registration of international pharmaceutical regulations, patents and trademarks, etc.

The international business section of Increasepharm is based on the cooperation’s Hong Kong branch and its Hong Kong research center. It integrates government, industry, university and research resources in the Guangdong-Hong Kong-Macao Greater Bay Area. It has cooperated with Hong Kong Baptist University, Macau University of Science and Technology, Hong Kong Polytechnic University, and The Chinese University of Hong Kong. Increasepharm conducted cooperation negotiations and communication activities with collages which mentioned all above. It cooperates with Hong Kong Baptist University to build a nucleic acid drug R&D platform; with Macau University of Science and Technology to jointly research the key technology platform for the atomization inhalation of compound Chinese medicine in the Guangdong-Hong Kong-Macao science and technology cooperation project, and with the Hong Kong Polytechnic University School of Optometry to establish an ophthalmology Joint Research Center for in situ gel medicine conducts innovative drug R&D cooperation. Besides, it will continue to actively explore a variety of international cooperation methods including cooperative development, product licensing, overseas strategic mergers and acquisitions, and provide more possibilities for the development of Increasepharm.

The international business section is based on the group’s strategic planning and provides platform services for the cooperation’s internationalization, including international market information research on the company’s research projects and planned and potential cooperation projects, global drug registration, registration of international patents and trademarks, international business cooperation, overseas strategic mergers and acquisitions and other related businesses services. The international business section serves as a hub for the Group to expand cooperation and exchanges with the global medical and health fields. Relying on Increasepharm's leading technology in the field of innovative drug R&D, rich patent layout and high-level expert team and other professional resources. A professional international cooperation platform for docking international partners and developing drugs to the world.

Scan the WeChat QR code